The DRFZ has restructured its research areas and now comprises four areas. Two new program areas have been formed from the previously largest program area Pathophysiology of Rheumatic Inflammation:
Cell and Tissue Rheumatology (program area 1 headed by Prof. Dr. Anja Hauser and Translational Rheumatology (program area 4) headed by PD Dr. Tobias Alexander.
Program area 1 Cell and Tissue Rheumatology
The “Cell and Tissue Rheumatology” programme area investigates the mechanisms of chronic inflammation using preclinical models and patient data. The aim is to enable innovative therapies that interrupt inflammatory processes and offer long-term healing prospects.
Program area 4: Translational Rheumatology
The aim of program area 4 is to promote the development of effective diagnoses and new therapeutic approaches in rheumatology. The focus is on the identification and validation of biomarkers for early and precise diagnosis and research into new cellular therapeutic targets.